Washington — According to five people familiar with the search for candidates, the White House is considering appointing former Commissioner of Food and Drugs Dr. Robert M. Caliph to lead the agency again.
Public health says the FDA lacks a permanent chair since President Biden took office, flooding with reviews of coronavirus vaccines, while the FDA lacks a clear direction during the fierce pandemic. There was frequent criticism from experts. , Testing and treatment.
Those familiar with the search process said no final decision was made. Dr. Janet Woodcock, a longtime drug regulator at the FDA’s deputy commissioner, is nearing the end of the period in which deputy officials are allowed to serve.
Dr. Caliph declined to comment. News of his potential nomination was first reported by The Washington Post.
Dr. Caliph, a cardiologist who teaches at Duke University School of Medicine, served only briefly as FDA Commissioner at the end of President Barack Obama’s second term. He was a Deputy Commissioner for Medical Products and Tobacco Distributors before leading it from February 2016 to January 2017.
He was Confirmed In February 2016, the Senate voted 89-4 as a member after some lawmakers opposed his nomination for what they said was an inadequate record of the authorities on prescription analgesics. His nomination faced the most intense backlash from the Democratic Party.
Katie Rogers, Sharon Lafraniere When Katie Thomas Contribution report.
Biden is considering Robert Califf leading the FDA again
Source link Biden is considering Robert Califf leading the FDA again